These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18540170)

  • 21. Thrombin as a common downstream target blocking both platelet and monocyte activation.
    Santilli F; Davì G
    Thromb Haemost; 2009 Feb; 101(2):220-1. PubMed ID: 19190800
    [No Abstract]   [Full Text] [Related]  

  • 22. Design and synthesis of new N-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides as anti-inflammatory agents.
    Yen CT; Hwang TL; Wu YC; Hsieh PW
    Eur J Med Chem; 2009 May; 44(5):1933-40. PubMed ID: 19110343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rivaroxaban: mode of action].
    Drouet L
    Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S9-15. PubMed ID: 19185786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a novel dermatan sulfate with high antithrombin activity from ray skin (Raja radula).
    Ben Mansour M; Dhahri M; Bertholon I; Ollivier V; Bataille I; Ajzenberg N; Hassine M; Jandrot-Perrus M; Chaubet F; Maaroufi RM
    Thromb Res; 2009 Apr; 123(6):887-94. PubMed ID: 19019412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of new anticoagulants: present and future.
    Harenberg J
    Semin Thromb Hemost; 2008 Nov; 34(8):779-93. PubMed ID: 19214916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors.
    Steffel J; Lüscher TF
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):616-23. PubMed ID: 19561526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of anticoagulants and the role of thrombin on neutrophil-endothelial cell interactions in septic shock.
    Tsen A; Kirschenbaum LA; LaRow C; Khan R; Kurtz S; Bansal S; Astiz ME
    Shock; 2009 Feb; 31(2):120-4. PubMed ID: 18636042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, biological evaluation, and structure-activity relationship (SAR) discussion of dipeptidyl boronate proteasome inhibitors, part I: comprehensive understanding of the SAR of alpha-amino acid boronates.
    Zhu Y; Zhao X; Zhu X; Wu G; Li Y; Ma Y; Yuan Y; Yang J; Hu Y; Ai L; Gao Q
    J Med Chem; 2009 Jul; 52(14):4192-9. PubMed ID: 19537716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel oral anticoagulants.
    Khoo CW; Tay KH; Shantsila E; Lip GY
    Int J Clin Pract; 2009 Apr; 63(4):630-41. PubMed ID: 19222611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simple peptides. II. Syntheses and properties of taurine-dipeptides containing neutral alpha-amino acid.
    Ienaga K; Higashiura K; Toyomaki Y; Matsuura H; Kimura H
    Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):70-7. PubMed ID: 3378309
    [No Abstract]   [Full Text] [Related]  

  • 31. Novel oral anticoagulants and diet: the potential for interaction.
    Kamali F
    Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
    Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
    Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo.
    Sheffield WP; Eltringham-Smith LJ; Gataiance S; Bhakta V
    Thromb Haemost; 2009 May; 101(5):867-77. PubMed ID: 19404540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation.
    Hammwöhner M; Goette A
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):18-27. PubMed ID: 18594479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.
    Tomita K; Oishi S; Ohno H; Peiper SC; Fujii N
    J Med Chem; 2008 Dec; 51(23):7645-9. PubMed ID: 19007202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total synthesis and determination of the absolute configuration of guadinomines B and C2.
    Hirose T; Sunazuka T; Tsuchiya S; Tanaka T; Kojima Y; Mori R; Iwatsuki M; Omura S
    Chemistry; 2008; 14(27):8220-38. PubMed ID: 18655091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate.
    Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM
    Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of boronic acid derivatives of tyropeptin: proteasome inhibitors.
    Watanabe T; Momose I; Abe M; Abe H; Sawa R; Umezawa Y; Ikeda D; Takahashi Y; Akamatsu Y
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2343-5. PubMed ID: 19307118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on peptides. XCIV. Synthesis and activity of kyotorphin and its analogs.
    Yajima H; Ogawa H; Ueda H; Takagi H
    Chem Pharm Bull (Tokyo); 1980 Jun; 28(6):1935-8. PubMed ID: 7408060
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and application of dipeptides; current status and perspectives.
    Yagasaki M; Hashimoto S
    Appl Microbiol Biotechnol; 2008 Nov; 81(1):13-22. PubMed ID: 18795289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.